Drawing for STRATEVI

USPTO serial 98028590

STRATEVI

Reviewed by CopyMark Law Group

Reg. 8170147Status 700Registered
Filing date
Status date
Registration date
Mar 10, 2026
Examiner
CHOSID, ROBIN S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with STRATEVI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anuj Desai

Anuj Desai Arnall Golden Gregory LLPSuite 2100171 17th Street NWAtlanta, GA 30363

Goods and services

ClassDescriptionStatusFirst use
042Application service provider featuring application programming interface (API) software that permits users to manage and track projects, deliverables, invoicing, and budgets via customizable computer dashboards in the field of healthcare, pharmaceuticals, biotechnology, and medical devices; Platform as a service (PAAS) featuring computer software platforms for use in connection with health economics and outcomes research (HEOR), the foregoing used by pharmaceutical, biotechnology and medical device companies to support their business decision making and internal communications with respect to the development, valuation, and pricing of products and therapies and related projects;  Providing a web site featuring technology that enables users to analyze, describe, track, manage, visualize, and share data regarding the user's health economics and outcomes research (HEOR) through a customizable computer dashboard interface, for use in the healthcare, pharmaceutical, biotechnology, and medical device industries; Software as a service (SAAS) services featuring software for the analysis, tracking, management, and visualization of an organization's project budgets, key decisions, scientific evidence, data received from international markets, and communications pertaining to the economic value of a particular product or therapy, for use in the healthcare, pharmaceutical, biotechnology, and medical device industries; Software as a service (SAAS) services featuring software for the management of projects, deliverables, budgets, evidence, and business data, the foregoing for use in connection with health economics and outcomes research (HEOR) and commercial functions and projects in the healthcare, pharmaceutical, biotechnology, and medical device industries; Software as a service (SAAS) services, namely, hosting software for use by others for the visualization and management of projects, deliverables, budgets, evidence, and business data for use in connection with health economics and outcomes research (HEOR) and commercial functions and projects in the healthcare, pharmaceutical, biotechnology, and medical device industriesACTIVENov 9, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 10, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 10, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 18, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 18, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 18, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 8, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 8, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 8, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 8, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 15, 2025IUAFUSE AMENDMENT FILED—
Aug 15, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 3, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 8, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 8, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 2, 2025DOCKASSIGNED TO EXAMINER—
Apr 2, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 18, 2025PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Feb 27, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 27, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 27, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 6, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 6, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 6, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2024ALIEASSIGNED TO LIE—
Jul 19, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 19, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 22, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 20, 2024DOCKASSIGNED TO EXAMINER—
Jul 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 8, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance